Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.

@article{Wang2020ClinicalCO,
  title={Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.},
  author={Dawei Wang and Bo Hu and Chang Hu and Fangfang Zhu and Xing Liu and Jing Zhang and Binbin Wang and Hui Xiang and Zhenshun Cheng and Yong Xiong and Yan Zhao and Yirong Li and Xinghuan Wang and Zhiyong Peng},
  journal={JAMA},
  year={2020}
}
Importance In December 2019, novel coronavirus (2019-nCoV)-infected pneumonia (NCIP) occurred in Wuhan, China. The number of cases has increased rapidly but information on the clinical characteristics of affected patients is limited. Objective To describe the epidemiological and clinical characteristics of NCIP. Design, Setting, and Participants Retrospective, single-center case series of the 138 consecutive hospitalized patients with confirmed NCIP at Zhongnan Hospital of Wuhan University… Expand
Epidemiological and Clinical Characteristics of 17 Hospitalized Patients with 2019 Novel Coronavirus Infections Outside Wuhan, China
TLDR
Data from 17 confirmed cases of novel coronavirus pneumonia infected with 2019-nCoV in Dazhou provided some information that younger age, higher lymphocytes levels and monocytes levels at the diagnoses of 2019- nCoV may contributed to faster recovery and better therapeutic outcome. Expand
Presenting Characteristics, Comorbidities, and Outcomes Among Hospitalized Patients with 2019 Novel Coronavirus-infected Pneumonia in Tehran, Iran
TLDR
Hospitalized NCIP patients who have serious underlying chronic illness might be at higher risk for severe illness and what is the epidemiological, clinical, laboratory, radiological characteristics, and outcomes of the disease. Expand
Clinical characteristics of 60 discharged cases of 2019 novel coronavirus-infected pneumonia in Taizhou, China.
TLDR
Early therapy and comprehensive therapy are key to the outcome for patients with COVID-19-infected pneumonia, especially for those with severe pneumonia. Expand
Clinical Features and Treatment of 221 Patients with COVID-19 in Wuhan, China
TLDR
55 severe patients with elder age and chronic comorbidities, developed more than one complication and the mortality rate was significantly higher in the severe patients compared to that in the non-severe patients, suggesting that the delayed use of corticosteroid might increase the risk of death in ICU. Expand
Clinical Characteristics of Patients with Severe Pneumonia Caused by the 2019 Novel Coronavirus in Wuhan, China
TLDR
Clinicians should focus on advanced age, lymphocyte decline, and D-dimer elevation are important characteristics of patients with severe pneumonia to identify high-risk patients at an early stage of the disease. Expand
Clinical characteristics of 51 patients discharged from hospital with COVID-19 in Chongqing,China
TLDR
The epidemiological and clinical characteristics of COVID-19 in non-Wuhan area are described, its effective treatment is explored, and the common clinical symptoms disappeared basically. Expand
Clinical and Laboratory Profiles of 75 Hospitalized Patients with Novel Coronavirus Disease 2019 in Hefei, China
TLDR
It is concluded that COVID-19 could cause different degrees of hematological abnormalities and damage of internal organs andAntiviral treatment requires a comprehensive and supportive approach. Expand
Clinical Findings of Patients with Coronavirus Disease 2019 in Jiangsu Province, China: A Retrospective, Multi-Center Study
TLDR
In this case series in Jiangsu Province, COVID-19 patients had less severe symptoms and had better outcomes than the initial COVID -19 patients in Wuhan. Expand
Clinical findings of patients with coronavirus disease 2019 in Jiangsu province, China: A retrospective, multi-center study
TLDR
In this case series in Jiangsu Province, COVID-19 patients had less severe symptoms and had better outcomes than the initial COVID theses in Wuhan, and the BMI ≥ 28 kg/m2 and a known history of type 2 diabetes were independent risk factors of severe illness in patients with CO VID-19. Expand
Clinical Features and Short-term Outcomes of 102 Patients with Corona Virus Disease 2019 in Wuhan, China
  • Jianlei Cao, W. Tu, +4 authors Q. Liu
  • Medicine
  • Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
  • 2020
TLDR
The data support those described by others that COVID-19 infection results from human-to-human transmission, including familial clustering of cases, and nosocomial transmission. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 41 REFERENCES
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
TLDR
The epidemiological, clinical, laboratory, and radiological characteristics and treatment and clinical outcomes of patients with laboratory-confirmed 2019-nCoV infection in Wuhan, China, were reported. Expand
Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study
TLDR
Characteristics of patients who died were in line with the MuLBSTA score, an early warning model for predicting mortality in viral pneumonia, and further investigation is needed to explore the applicability of the Mu LBSTA scores in predicting the risk of mortality in 2019-nCoV infection. Expand
Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia
TLDR
There is evidence that human-to-human transmission has occurred among close contacts since the middle of December 2019 and considerable efforts to reduce transmission will be required to control outbreaks if similar dynamics apply elsewhere. Expand
A Novel Coronavirus from Patients with Pneumonia in China, 2019
TLDR
Human airway epithelial cells were used to isolate a novel coronavirus, named 2019-nCoV, which formed a clade within the subgenus sarbecovirus, Orthocoronavirinae subfamily, which is the seventh member of the family of coronaviruses that infect humans. Expand
Clinical Time Features and Chest Imaging of 85 Patients With COVID-19 in Zhuhai, China
TLDR
The incubation period of SARS-CoV-2 may be longer than 14 days; thus, medical surveillance after contact is required for longer than this. Expand
Clinical Features, Diagnosis, and Treatment of COVID-19 in Hospitalized Patients: A Systematic Review of Case Reports and Case Series
TLDR
Development of ARDS may play a role in estimating disease progression and mortality risk and early detection of elevations in serum CRP, combined with a clinical COVID-19 symptom presentation may be used as a surrogate marker for the presence and severity of the disease. Expand
Coronavirus Disease 2019: A Comprehensive Review of Etiology, Pathogenesis, Diagnosis, and Ongoing Clinical Trials
TLDR
The off-label use of drugs such as hydroxychloroquine and emergency use authorization of remdesivir can hopefully help the clinicians while treating critically ill patients and the use of convalescent serum has shown some interim benefit until a definitive treatment and preventive options are uncovered. Expand
A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster
TLDR
The findings are consistent with person-to-person transmission of this novel coronavirus in hospital and family settings, and the reports of infected travellers in other geographical regions. Expand
Clinical Characteristics and Reasons for Differences in Duration From Symptom Onset to Release From Quarantine Among Patients With COVID-19 in Liaocheng, China
TLDR
The majority of COVID-19 cases in the study area were mild and moderate, with good clinical outcomes, and the reasons for differences in the duration from symptom onset to release from quarantine were complex. Expand
Novel Insights Into Illness Progression and Risk Profiles for Mortality in Non-survivors of COVID-19
TLDR
The data show that patients experienced consecutive changes in biochemical and immune parameters with the deterioration of the disease, indicating the necessity of early intervention. Expand
...
1
2
3
4
5
...